RYTM
Price:
$96.79
Market Cap:
$6.64B
Rhythm Pharmaceuticals, Inc. is a biopharmaceutical company with commercial products, dedicated to the discovery, development, and market launch of therapies addressing rare genetic conditions that cause obesity. Its leading pharmaceutical, IMCIVREE, functions as a powerful agonist of the melanocortin-4 receptor (MC4R). This medication is indicated for treating obesity stemming from deficiencies in pro-opiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1 (PCSK1), or the leptin receptor (LEPR), alongside its use in patients with Bardet-Biedl and Alström syndromes. Furthermore, the company is progressing setmelanotide (the active compound in IMCIVREE) through Phase II clinica...[Read more]
Industry
Biotechnology
IPO Date
2017-10-09
Stock Exchange
NASDAQ
Ticker
RYTM
According to Rhythm Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.
The mean historical Dividend Yield of Rhythm Pharmaceuticals, Inc. over the last ten years is 0.01%. The current 0% Dividend Yield has changed -100.00% with respect to the historical average. Over the past ten years (40 quarters), RYTM's Dividend Yield was at its highest in in the June 2016 quarter at 0%. The Dividend Yield was at its lowest in in the June 2016 quarter at 0%.
Average
0.01%
Median
0%
Minimum
0%
Maximum
0.12%
Discovering the peaks and valleys of Rhythm Pharmaceuticals, Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Dividend Yield = 0.12%
Minimum Annual Increase = 0%
Minimum Annual Dividend Yield = 0%
| Year | Dividend Yield | Change |
|---|---|---|
| 2025 | 0% | -100.00% |
| 2024 | 0.12% | Infinity% |
| 2023 | 0% | 0% |
| 2022 | 0% | 0% |
| 2021 | 0% | 0% |
| 2020 | 0% | 0% |
| 2019 | 0% | 0% |
| 2018 | 0% | 0% |
| 2017 | 0% | 0% |
| 2016 | 0% | 0% |
The current Dividend Yield of Rhythm Pharmaceuticals, Inc. (RYTM) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0.04%
5-year avg
0.02%
10-year avg
0.01%
Rhythm Pharmaceuticals, Inc.’s Dividend Yield is less than Revolution Medicines, Inc. (0%), less than Akero Therapeutics, Inc. (0%), less than Atrium Therapeutics, Inc. (0%), less than Protagonist Therapeutics, Inc. (0%), less than Stoke Therapeutics, Inc. (0%), less than uniQure N.V. (0%), less than Rocket Pharmaceuticals, Inc. (0%), less than Solid Biosciences Inc. (0%), less than MeiraGTx Holdings plc (0%), less than Nuvalent, Inc. (0%), less than Ventyx Biosciences, Inc. (0%), less than Arcellx, Inc. (0%), less than Cullinan Therapeutics, Inc. (0%), less than Kiniksa Pharmaceuticals, Ltd. (0%), less than Pliant Therapeutics, Inc. (0%), less than Syndax Pharmaceuticals, Inc. (0%), less than Viridian Therapeutics, Inc. (0%), less than Inozyme Pharma, Inc. (0%), less than Relay Therapeutics, Inc. (0%), less than Black Diamond Therapeutics, Inc. (0%), less than Arvinas, Inc. (0%),
| Company | Dividend Yield | Market cap |
|---|---|---|
| 0% | $34.65B | |
| 0% | $4.50B | |
| 0% | $216.56M | |
| 0% | $7.26B | |
| 0% | $1.93B | |
| 0% | $2.92B | |
| 0% | $365.80M | |
| 0% | $648.99M | |
| 0% | $1.05B | |
| 0% | $9.08B | |
| 0% | $1.00B | |
| 0% | $6.73B | |
| 0% | $923.71M | |
| 0% | $4.14B | |
| 0% | $71.83M | |
| 0% | $1.68B | |
| 0% | $1.50B | |
| 0% | $258.25M | |
| 0% | $2.78B | |
| 0% | $95.12M | |
| 0% | $494.88M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Rhythm Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Rhythm Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Dividend Yield?
How can you use the Dividend Yield?
What is Rhythm Pharmaceuticals, Inc.'s Dividend Yield?
How is the Dividend Yield calculated for Rhythm Pharmaceuticals, Inc. (RYTM)?
What is the highest Dividend Yield for Rhythm Pharmaceuticals, Inc. (RYTM)?
What is the 3-year average Dividend Yield for Rhythm Pharmaceuticals, Inc. (RYTM)?
What is the 5-year average Dividend Yield for Rhythm Pharmaceuticals, Inc. (RYTM)?
How does the current Dividend Yield for Rhythm Pharmaceuticals, Inc. (RYTM) compare to its historical average?